ReNetX Bio, Inc. — Form D/A

ReNetX Bio, Inc. of NEW HAVEN, CT, a company, filed a Form D amendment with the SEC on 2019-07-09. The offering totals $3.2M, of which $3.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
John R PuzissDirectorNew Haven, CT
Erika R SmithDirectorNew Haven, CT
David R WurzerDirectorRocky Hill, CT
Erika R SmithExecutive OfficerNew Haven, CT
ERIKA SMITHDirectorBALTIMORE, MD
ERIKA SMITHExecutive OfficerBALTIMORE, MD
Gregory HoDirectorNew York, NY
David WurzerDirectorMystic, CT
John PuzissDirectorNew Haven, CT
George MaynardExecutive OfficerNew Haven, CT
Jane HendersonExecutive OfficerNew York, NY
David M WurzerDirectorRocky Hill, CT
David I ScheerDirectorEast Norriton, PA
David I ScheerPromoterEast Norriton, PA
Amanda HaywardDirectorNew Haven, CT
Amanda HaywardExecutive OfficerNew Haven, CT
Amanda HaywardPromoterNew Haven, CT
Scheer Investment M Holdings X, LLCPromoterNew Haven, CT
Stephen M StrittmatterPromoterNew Haven, CT
Sylvia McBrinnDirectorNew Haven, CT
Sylvia McBrinnExecutive OfficerNew Haven, CT
Sylvia McBrinnPromoterNew Haven, CT

Other filings by this issuer (5)

FiledFormOfferingSold
2020-09-28D/A$2.8M$2.8M
2019-12-02D$5.5M$1.3M
2018-04-09D$2.8M$1.7M
2017-12-29D$450K$425K
2010-04-14D$758K$758K

More